大豆基婴幼儿配方奶粉市场－全球产业规模、份额、趋势、机会与预测：按形态、类型、通路、地区和竞争格局划分，2021-2031年

全球大豆婴儿配方奶粉市场预计将从 2025 年的 3.0832 亿美元成长到 2031 年的 4.0554 亿美元，复合年增长率为 4.67%。

大豆配方奶粉是专为婴儿设计的营养替代品，采用强化大豆分离蛋白，为患有半乳糖血症、遗传性乳糖酶缺乏症或牛奶蛋白过敏的婴儿提供全面的营养补充方案。该领域的成长主要受乳糖不耐受诊断病例增加以及越来越多的父母倾向于选择符合伦理或植物性饮食的生活方式的推动。植物性食品协会的报告也印证了这个趋势：预计到2024年，美国植物性食品产业的销售额将达到81亿美元，显示消费者正大力转向无乳製品选择。这为支撑大豆配方奶粉的需求奠定了基础。

儘管市场趋势向好，但大豆蛋白中天然存在的植物雌激素可能产生的生物学效应，给该行业带来了重大挑战。由于担心荷尔蒙发育和内分泌紊乱，医疗保健专业人员和监管机构经常警告不要给六个月以下的婴儿使用奶粉配方奶粉。由于严格审查，大豆配方奶粉仍然是水解牛奶配方奶粉的次要替代品，难以成为主流餵食方案，只能作为一种小众的医疗或生活方式选择。

市场驱动因素

牛奶蛋白过敏和乳糖不耐症的日益普遍是推动豆基婴儿奶粉持续普及的关键临床因素。豆基奶粉是无法代谢乳蛋白或乳糖的婴儿的标准替代品，能够提供必要的营养保护，尤其适用于非IgE介导的过敏症（症状主要影响消化器官系统的类型）。专注于特殊治疗产品的行业领导企业表现出色，进一步强化了这项医疗需求。根据Food Navigator发布的2025年2月全年财报，达能特种营养品部门的销售额增长了4.6%，凸显了消费者对专门用于应对这些食物过敏的配方奶粉的持续依赖。

同时，父母对植物来源和纯素婴幼儿营养品的兴趣日益浓厚，正推动市场从单纯的医疗需求拓展至生活风格领域。现代父母越来越重视洁净标示、永续性和不含动物成分的营养，这促使生产商加强供应链运营，并提升非乳製品替代品的商业性可行性。这种向道德消费的转变正在提升营运效率。例如，Else Nutrition在2025年11月公布的第三季收益成长了34%，显示植物来源领域的财务状况日趋成熟。此外，雅培2025年报告显示，2024年全年销售额达到420亿美元，展现了庞大的市场规模，这不仅支持了全球儿童营养领域的创新，也显示整个产业仍在大规模运作。

市场挑战

大豆蛋白中所含的植物雌激素因其潜在的生物效应，对全球大豆婴儿配方奶粉市场的成长构成重大阻碍。由于这些化合物会模拟天然雌激素的作用，监管机构和医疗专业人士严格限制此类产品的使用，因为它们可能对婴儿的内分泌系统和长期荷尔蒙发育产生不利影响。这种医学上的谨慎使得大豆配方奶粉几乎不可能作为主流的植物性饮食选择进行销售，而是被视为最后的营养治疗手段。

因此，大豆配方奶粉通常被排除在六个月以下婴儿的标准护理之外，这大大缩小了潜在消费群体。此外，由于大豆製品通常仅用于治疗特定疾病而非日常保健，市场也面临其他限制。根据英国营养师协会2024年的数据显示，婴儿牛奶蛋白过敏的盛行率估计仅为2%，但即使在这一小部分族群中，由于上述安全隐患，临床指引通常也建议使用水解配方奶粉而非大豆配方奶粉。这种监管优先性使得该产品成为小众医疗干预措施，而非一种广泛可用的营养选择，从而限制了其市场规模。

市场趋势

全球大豆婴幼儿奶粉市场的一项重大发展是益生元和益生菌的添加。这直接解决了人们长期以来对植物蛋白消化率低于母乳的担忧。製造商越来越多地在大豆分离蛋白中添加人类乳寡糖 (HMO) 和特定菌株，以提高营养吸收率并优化婴幼儿肠道菌丛。这使得这些产品从单纯的过敏原规避工具转变为功能性营养解决方案。对先进配方的关注正在加强原材料供应链。例如，帝斯曼-菲美意公司 (DSM-Firmenich) 于 2025 年 2 月报告称，其健康、营养与护理业务部门在 2024 年实现了 6% 的有机销售增长，这主要得益于对 HMO 等婴幼儿必需营养成分需求的增长。

同时，采购有机种植和非基因改造大豆的战略方向也明显转变。这主要源自于父母对透明度的强烈需求，以及他们对婴幼儿食品中合成农药的抗拒。由于大豆通常与基因改造联繫在一起，高端品牌正日益采用严格的有机认证供应链，以降低消费者的健康担忧，并在竞争激烈的市场中脱颖而出。这一趋势对品类成长产生了显着影响；根据有机贸易协会2025年4月发布的报告，有机婴幼儿食品和配方奶粉产业在2024年实现了16亿美元的销售额，巩固了其作为有机食品行业第二大品类的地位。这表明，对于生产商而言，获得洁净标示大豆认证在商业性至关重要。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：大豆婴幼儿配方奶粉的全球市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依型态（粉末、液体、半液体）
  • 依类型（低脂大豆婴儿配方奶粉，全脂大豆婴儿配方奶粉）
  • 分销通路（线上、线下）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美大豆婴儿配方奶粉市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲大豆婴幼儿配方奶粉市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区大豆婴幼儿配方奶粉市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲大豆婴儿配方奶粉市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲大豆婴儿配方奶粉市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球大豆婴幼儿配方奶粉市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Danone SA
• HiPP GmbH & Co. Vertrieb KG
• Nestle SA
• Abbott Laboratories
• The Kraft Heinz Company
• Reckitt Benckiser Group PLC
• Heilongjiang Feihe Dairy Co., Ltd.
• Arla Foods amba
• Kerry Group plc
• Royal FrieslandCampina NV

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Soy Based Infant Formula Market is projected to expand from USD 308.32 Million in 2025 to USD 405.54 Million by 2031, registering a CAGR of 4.67%. Designed as a specialized nutritional alternative, soy-based infant formula utilizes soy protein isolate fortified with vital nutrients to serve as a comprehensive feeding solution for babies suffering from galactosemia, hereditary lactase deficiency, or allergies to cow's milk protein. Growth in this sector is largely sustained by increasing diagnoses of dairy intolerances and a rising parental preference for ethical or plant-centric lifestyles. Highlighting this trend, the Plant Based Foods Association reported that the United States plant-based foods sector generated $8.1 billion in sales in 2024, demonstrating a robust consumer transition toward dairy-free options that underpins the demand for soy formulations.

Despite these favorable market forces, the industry encounters significant hurdles related to the potential biological effects of phytoestrogens naturally found in soy protein. Due to apprehensions regarding hormonal development and endocrine disruption, medical authorities and regulatory agencies frequently advise caution against using soy formula for infants under six months of age. Consequently, this scrutiny restricts the product to a secondary alternative behind hydrolyzed cow's milk formulas, preventing it from becoming a mainstream feeding solution and keeping it positioned as a niche medical or lifestyle option.

Market Driver

The escalating prevalence of Cow's Milk Protein Allergy and Lactose Intolerance serves as the principal clinical factor fueling the continued adoption of soy-based infant formulations. Functioning as the standard substitute for infants incapable of metabolizing dairy proteins or lactose, soy formula offers an essential nutritional safeguard, specifically for those with non-IgE mediated allergies where symptoms primarily impact the gastrointestinal system. This medical imperative is further strengthened by the strong performance of industry leaders focusing on specialized therapeutic products; according to Food Navigator's coverage of Danone's full-year results in February 2025, the company's specialized nutrition division recorded a 4.6% increase in sales, underscoring persistent consumer dependence on formulations tailored for managing such dietary sensitivities.

Simultaneously, the growing parental inclination toward Plant-Based and Vegan Infant Nutrition is broadening the market's reach beyond strict medical necessities into the lifestyle sector. Modern parents are increasingly prioritizing clean-label, sustainable, and animal-free nutritional options, which is driving manufacturers to enhance supply chain operations and improve the commercial feasibility of non-dairy alternatives. This movement toward ethical consumption is resulting in greater operational efficiency; for instance, Else Nutrition reported in its November 2025 Q3 financial results that its gross profit margin rose to 34%, indicating increased financial maturity within the plant-based category. Additionally, the wider industry continues to operate at a massive scale, evidenced by Abbott's 2025 report showing full-year 2024 sales of $42.0 billion, revealing the immense market capitalization that supports global innovation in pediatric nutrition.

Market Challenge

The presence of phytoestrogens in soy protein constitutes a significant obstacle to the growth of the global soy-based infant formula market due to concerns over their potential biological impact. Since these compounds naturally mimic estrogen, regulatory bodies and medical experts strictly limit the product's use, citing potential adverse risks to infant endocrine systems and long-term hormonal development. This medical caution effectively precludes soy formula from being marketed as a mainstream plant-based lifestyle option for the general infant population, instead designating it as a nutritional treatment of last resort.

As a result, soy formula is frequently omitted from the standard of care for infants under six months, which substantially reduces its potential consumer base. The market faces further constraints because soy is typically prescribed only for specific medical conditions rather than recommended for general use. According to the British Dietetic Association in 2024, the prevalence of cow's milk protein allergy in young children was estimated at just 2%, yet even within this small demographic, clinical guidelines generally favor hydrolyzed formulas over soy alternatives because of the previously mentioned safety issues. This regulatory hierarchy limits market volume by defining the product as a niche medical intervention rather than a broadly accessible nutritional choice.

Market Trends

A pivotal development in the Global Soy Based Infant Formula Market is the incorporation of prebiotics and probiotics, which directly tackles historical apprehensions regarding the digestibility of plant proteins relative to human milk. Manufacturers are increasingly enhancing soy isolates with Human Milk Oligosaccharides (HMOs) and specific bacterial strains to improve nutrient absorption and optimize the infant microbiome, thereby elevating these products from simple allergen-avoidance tools to functional nutritional solutions. This emphasis on advanced formulation is strengthening the ingredient supply chain; for example, DSM-Firmenich reported in February 2025 that its Health, Nutrition & Care business unit achieved 6% organic sales growth in 2024, driven significantly by rising demand for essential early-life nutrition ingredients such as HMOs.

In parallel, there is a distinct strategic movement toward organic and non-GMO soy sourcing, fueled by parental insistence on transparency and the exclusion of synthetic pesticides from infant diets. Because soy is often linked to genetic modification, premium brands are rigorously implementing certified organic supply chains to alleviate health concerns and distinguish their products in a competitive market. This trend is resulting in measurable category growth; according to the Organic Trade Association's April 2025 report, the organic baby food and formula sector solidified its position as the second-largest organic grocery segment with 2024 sales reaching $1.6 billion, underscoring the commercial imperative for manufacturers to obtain clean-label soy certifications.

Key Market Players

• Danone S.A.
• HiPP GmbH & Co. Vertrieb KG
• Nestle S.A.
• Abbott Laboratories
• The Kraft Heinz Company
• Reckitt Benckiser Group PLC
• Heilongjiang Feihe Dairy Co., Ltd.
• Arla Foods amba
• Kerry Group plc
• Royal FrieslandCampina N.V.

Report Scope

In this report, the Global Soy Based Infant Formula Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Soy Based Infant Formula Market, By Form

• Powder
• Liquid
• Semi-Liquid

Soy Based Infant Formula Market, By Type

• Low Fat Soy-based Infant Formula
• Whole-Fat Soy-based Infant Formula

Soy Based Infant Formula Market, By Distribution Channel

• Online
• Offline

Soy Based Infant Formula Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Soy Based Infant Formula Market.

Available Customizations:

Global Soy Based Infant Formula Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Soy Based Infant Formula Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Form (Powder, Liquid, Semi-Liquid)
  • 5.2.2. By Type (Low Fat Soy-based Infant Formula, Whole-Fat Soy-based Infant Formula)
  • 5.2.3. By Distribution Channel (Online, Offline)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Soy Based Infant Formula Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Form
  • 6.2.2. By Type
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Soy Based Infant Formula Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Form
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Soy Based Infant Formula Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Form
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Soy Based Infant Formula Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Form
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Distribution Channel

7. Europe Soy Based Infant Formula Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Form
  • 7.2.2. By Type
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Soy Based Infant Formula Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Form
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. France Soy Based Infant Formula Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Form
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Soy Based Infant Formula Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Form
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Soy Based Infant Formula Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Form
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Soy Based Infant Formula Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Form
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Soy Based Infant Formula Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Form
  • 8.2.2. By Type
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Soy Based Infant Formula Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Form
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Soy Based Infant Formula Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Form
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Soy Based Infant Formula Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Form
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Soy Based Infant Formula Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Form
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Soy Based Infant Formula Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Form
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Soy Based Infant Formula Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Form
  • 9.2.2. By Type
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Soy Based Infant Formula Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Form
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. UAE Soy Based Infant Formula Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Form
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. South Africa Soy Based Infant Formula Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Form
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Distribution Channel

10. South America Soy Based Infant Formula Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Form
  • 10.2.2. By Type
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Soy Based Infant Formula Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Form
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Colombia Soy Based Infant Formula Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Form
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. Argentina Soy Based Infant Formula Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Form
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Soy Based Infant Formula Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Danone S.A.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. HiPP GmbH & Co. Vertrieb KG
• 15.3. Nestle S.A.
• 15.4. Abbott Laboratories
• 15.5. The Kraft Heinz Company
• 15.6. Reckitt Benckiser Group PLC
• 15.7. Heilongjiang Feihe Dairy Co., Ltd.
• 15.8. Arla Foods amba
• 15.9. Kerry Group plc
• 15.10. Royal FrieslandCampina N.V.

16. Strategic Recommendations

17. About Us & Disclaimer